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Brief Technique ReportsC cardioplegia administered simultaneously into the
ascending aorta and isolated MPA/proximal branch PA;
and
C reimplantation of ALCAPA with generous buttons to
avoid distortion.
Alternative options would be a hybrid approach with PA
banding distal to ALCAPA and reimplantation at time of
comprehensive stage II, or neonatal transplantation.CONCLUSIONS
The preoperative diagnosis of this rare entity is key
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119:358-67.Percutaneous mitral valve repair as a bail-out strategy for patients
with severe mitral regurgitation after cardiac surgeryOlaf Franzen, MD,a Moritz Seiffert, MD,b Stephan Baldus, MD,a Lenard Conradi, MD,b
Johannes Schirmer, MD,b Mathias Kubik, MD,b Thomas Meinertz, MD,a
Hermann Reichenspurner, MD, PhD,b and Hendrik Treede, MD,b Hamburg, GermanyWith excellent long-term results, surgical valve repair is the
standard treatment in patients with mitral valve (MV) dis-
ease, replacement being an option if reconstruction is not fea-
sible.1,2 In patients with prohibitive operative risk, the
MitraClip system (Abbott Laboratories, Abbott Park, Ill)
has accomplished promising preliminary results reducing
mitral regurgitation (MR).3,4 We performed this procedure
as a bail-out approach in high-risk patients with severe MR
not responding to intense medical therapy in the early post-
operative period after cardiac surgery.CLINICAL SUMMARY
From March to October 2009, 3 patients underwent coro-
nary artery bypass grafting, tricuspid valve replacement, oraortic valve replacement combined with tricuspid valve repair
at the University Heart Center Hamburg (Table 1). Preopera-
tively,mild tomoderateMRwasnoted. Postoperatively, severe
functional MR impeded hemodynamic stabilization necessi-
tating prolonged inotropic support. To avoid early redo surgery
associated with disproportional operative risk, an interven-
tional approach was chosen after interdisciplinary discussion.
Percutaneous MV repair was performed with the Mitra-
Clip device, a polyester-covered metal clip, as previously
described.5 Briefly, after introduction through the femoral
vein and transseptal puncture, the steerable device was ad-
vanced across theMV. The clip was then positioned, and the
leaflets were captured at the origin of the regurgitant jet
creating a double-orifice simulating Alfieri’s technique.
Clip implantation was performed under fluoroscopic and
transesophageal echocardiographic guidance (Figure 1).
Follow-up echocardiographic evaluation was performed at
discharge and 3 months after the procedure.
RESULTS
All 3 female patients (age, 71–78 years) were consid-
ered high-risk surgical candidates as predicted by stan-
dard risk-stratification tools (Table 1). Percutaneous MV
repair was performed 5 to 7 days after primary surgery.
Two clips were used in 2 of the patients, creating a tri-
ple-orifice area. MR was reduced from grade III–IV to
I–II allowing for hemodynamic recompensation. There
were no signs of mitral stenosis after clip implantation.rdiovascular Surgery c Volume 142, Number 1 227
TABLE 1. Clinical and procedural characteristics
Patients 1 2 3
Baseline clinical characteristics
Age (y) 78 76 71
Gender Female Female Female
BMI (kg/m2) 18 26 24
Morbidities and medical history Severe CAD
Persistent atrial fibrillation
Arterial hypertension
S/p surgery and radiation therapy
for breast cancer
Severe AS (III)
Severe TR (IV)
S/p pacemaker-implantation for
bradyarrhythmia
Arterial hypertension
Cerebrovascular stroke
Severe TR (IV)
Valvular cardiomyopathy
Intermittent atrial fibrillation
Arterial hypertension
Renal dysfunction
Primary surgery Quadruple CABG
Biatrial ablation
AV replacement (Mitroflow [Sorin
Group, Milano, Italy] 21 mm)
TV repair (Carpentier-Edwards
[Edwards Lifesciences, Irvine, Calif]
Classic annuloplasty ring 28 mm)
TV replacement (Hancock
[Medtronic Inc, Minneapolis,
Minn] 31 mm)
Biatrial ablation
Preoperative/postoperative MR I–II/III II/III–IV I/IV
MV pathology MVannulus dilatation with
coaptation gap, increased
postoperatively
Bileaflet prolapse
Aggravated MR postoperatively
New-onset functional restriction
of PML postoperatively
Ventricular function Poor LV function Poor LV function Moderate LV function
RV failure
NYHA IV IV IV
Logistic euroSCORE 60.3% 50.8% 70.8%
STS score for Mortality 14.0% 9.1% 38.4%
Intra-/postprocedural characteristics
Days after primary surgery 7 5 7
No. of implanted clips 2 2 4
Procedure time 221 min 201 min 300 min
Fluoroscopy time 40 min 31 min 61 min
MR I–II I–II II–III
MV EOA 2.5 cm2 2.0 cm2 2.2 cm2
MV gradient 6/4 mm Hg 10/3 mm Hg 8/4 mm Hg
3-mo follow-up
NYHA II II–III IV
MR I II III
Ventricular function Normal LV function Normal LV function Moderate LV function
RV dysfunction
AS, Aortic stenosis; AV, aortic valve; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; EOA, effective orifice area; LV, left ventricle;
MR, mitral regurgitation; MV, mitral valve; NYHA, New York Heart Association functional class; PML, posterior mitral leaflet; RV, right ventricle; STS, Society of Thoracic
Surgeons; TR, tricuspid regurgitation; TV, tricuspid valve.
Brief Technique ReportsThese patients were discharged to a rehabilitation facility
shortly thereafter and presented with enhanced ventricular
function and MR grade II at 3 months follow-up. New
York Heart Association status had improved from class
IV to II/III.
In 1 patient, restricted leaflet motion caused an almost free
MR after tricuspid valve replacement. Valve morphology
and a large coaptation gap of 13 mm between anterior and
posterior leaflets prevented regular clip implantation at the
origin of the MR jet for sufficient reduction of regurgitation.
Instead, 4 clips were implanted in a zipper-like approach
as a rare modification of the technique. Approximation of
the leaflets was achieved by clip implantation beginning at
the lateral aspects of the coaptation gap and proceeding228 The Journal of Thoracic and Cardiovascular Surgto the central part, thus reducing MR to grade II–III
(Figure 1) and allowing for hemodynamic stabilization and
weaning of inotropic support. Three months after initial sur-
gery, this patient was still hospitalized. Respiratory failure
with prolonged ventilation, renal failure, and critical illness
neuropathy in addition to the remaining MR complicated
this patient’s postoperative course. Follow-up echocardiog-
raphy displayed slightly improved left ventricular function
and persistent right ventricular dysfunction.
CONCLUSIONS
Our patients were not candidates for early redo surgery to
repair the MV because of significant comorbidities and he-
modynamic instability; thus, an interventional approachery c July 2011
FIGURE 1. Transesophageal Doppler echocardiography displaying the regurgitation jet before (A) and after (B) MitraClip (Abbott Laboratories, Abbott
Park, IL) implantation. Intraprocedural 3-dimensional transesophageal echocardiography displaying theMV before (C) and after (D) implantation of 2 clips
creating a triple-orifice area, with the steerable catheter still in place (D). MitraClip attached to the delivery catheter (E) (reprinted with permission from
Abbott Laboratories) and fluoroscopic control while positioning a fourth clip in patient number 3 with 3 clips already in place (F).
Brief Technique Reportswith the MitraClip device proved to be a valuable bail-out
strategy. Mild to moderate MR had been observed preoper-
atively in all patients without indication for MV surgery
following recent guidelines.1 Different causes were pre-
sumably responsible for the increase in MR postoperatively,
one being progressing annular dilatation. The impact of MR
was underestimated intraoperatively and the MV was left
alone to reduce exposition to extracorporeal circulation—
a shortsighted judgment in retrospect (patient 1). An
increased volume challenge to the left ventricle with dilata-
tion after tricuspid valve surgery may account for an aggra-
vated MR, bileaflet prolapse (patient 2) and an increased
coaptation gap caused by functional restriction of the
posterior mitral leaflet (patient 3) being the underlying
pathologies.
The MitraClip device was used to reduce regurgitation
and allow for hemodynamic stabilization, the potential
goal being definite valve repair or postponement of surgical
MV therapy to a later elective stage with a reducedThe Journal of Thoracic and Caoperative risk. The implantation of multiple clips and pro-
longed recompensation in 1 patient underscore the com-
plexity. Furthermore, the percutaneous approach falls
short of a ring annuloplasty, and the long-term implications
on the durability remain to be elucidated. Nevertheless, be-
cause of the promising results in this high-risk patient co-
hort, application in hemodynamically stable postoperative
patients in whom severe MR develops seems conceivable,
sparing these patients the burden of early redo surgery
with repeat exposition to extracorporeal circulation. The
utility of this technique needs to be validated in a larger pop-
ulation and over a longer follow-up period.
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ventricular septal defect on the beating heartBarry A. Love, MD,a Brian Whang, MD,b and Farzan Filsoufi, MD,b New York, NYWe report 2 cases of post-myocardial infarction ventricular
septal defect (PMI-VSD) closed successfully with Amplat-
zer septal occluders (AGAMedical Corp, Plymouth, Minn)
using a direct perventricular approach via median sternot-
omy. The procedures were performed on the beating heart
without cardiopulmonary bypass.CLINICAL SUMMARY
We describe 2 sexagenarian men hospitalized with acute
myocardial infarction and cardiogenic shock. In each,
cardiac catheterization revealed proximal occlusion of the
left anterior descending artery, and ventriculogram demon-
strated a large PMI-VSD. Step-up in pulmonary artery
saturation indicated pulmonary-to-systemic flow ratio of
3:1 and greater than 4:1 in each patient. Both received an
intra-aortic balloon pump and were referred for emergency
PMI-VSD closure.
Intraoperative transesophageal echocardiography in both
patients confirmed a large mid-muscular PMI-VSD (patient
1, 25 mm; patient 2, 28 mm) extending to the apex with left-
to-right shunt (Figure 1, A, B). A median sternotomy was
performed. Digital compression of the right ventricular
(RV) free wall identified the site on the RV directly opposite
the central portion of the PMI-VSD (Figure 1, C). In both
patients, this was approximately 4 cm basal to the cardiac
apex. A purse-string was placed, and an 18 g needle wasinserted through the purse-string, into the central portion
of the VSD, and into the LV cavity. A 0.038-inch–30-cm
J-wire was inserted into the LV. A 12F 13-cm Cook sheath
was advanced over the guidewire. In each patient,
a 34-mm Amplatzer septal occluder was then deployed.
The distal discwas delivered in the LV cavity and pulled flush
with the LV septum.With traction on the delivery system and
countertraction on the RV free wall, the proximal disc was
deployed on the exterior surface of the RV (Figure 2, A–
C). A 34-mm device was chosen so the left disc (50 mm)
would cover the defect and the adjacent infarcted muscle,
and extend to what appeared to be viable myocardium.
In the first patient, transesophageal echocardiography
showed closure of the VSD with minimal residual flow
(Figure 2, D). On postoperative day (POD) 1, he was extu-
bated and the intra-aortic balloon pump was removed. Echo-
cardiogram on POD 5 showed a tiny residual VSD, an LV
ejection fraction of 35%, and normal RV. The patient was
discharged on POD 5. He remained well for 3 weeks but re-
turned in acute low-output cardiac failure. Echocardiogram
showed minimal residual shunting but severely depressed
biventricular function. Despite inotropic support, progres-
sive acidosis developed and the patient died within 24 hours.
The second patient underwent off-pump left anterior de-
scending artery revascularization in the same setting, and he
was extubated on POD 1. Follow-up catheterization on
POD 10 showed a small residual VSD that was successfully
closed with a transcatheter Amplatzer muscular VSD oc-
cluder. The patient was discharged, and repeat catheteriza-
tion 5 months later showed minimal residual left-to-right
flow and a shunt fraction of less than 1.2:1. At 13 months
postoperatively, the patient is in New York Heart Associa-
tion class I–II.DISCUSSION
VSD complicates 0.2% of cases of acute myocardial
infarction.1 Most of these patients present with rapidery c July 2011
